247 related articles for article (PubMed ID: 30607196)
1. Valsartan Induced Melanoma?! First Description in Medical Literature!
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2018 Dec; 6(12):2378-2380. PubMed ID: 30607196
[TBL] [Abstract][Full Text] [Related]
2. Drug-Induced Melanoma: Irbesartan Induced Cutaneous Melanoma! First Description in the World Literature!
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2019 Jan; 7(1):114-116. PubMed ID: 30740172
[TBL] [Abstract][Full Text] [Related]
3. Irbesartan Induced Cutaneous Melanoma! Second Case in the Medical Literature!
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2019 Jan; 7(1):121-123. PubMed ID: 30740174
[TBL] [Abstract][Full Text] [Related]
4. CONGRESS REPORT OF THE 5TH NATIONAL CONGRESS OF THE BULGARIAN SOCIETY FOR DERMATOLOGIC SURGERY, SOFIA, 11TH MARCH 2023 WITH MAIN TOPICS: NITROSAMINES AS MOST POWERFUL TRIGGER FOR SKIN CANCER DEVELOPMENT AND PROGRESSION/PERSONALISED ONE STEP MELANOMA SURGERY AS POSSIBLE SKIN CANCER TREATMENT OPTION.
Kordeva S; Cardoso J; Tchernev G
Georgian Med News; 2023 Apr; (337):89-95. PubMed ID: 37354679
[TBL] [Abstract][Full Text] [Related]
5. NITROSOGENESIS OF CUTANEOUS MELANOMA: SIMULTANEOUSLY DEVELOPMENT OF PRIMARY CUTANEOUS THICK MELANOMA OF THE BREAST, THIN MELANOMA/DYSPLASTIC MOLE OF THE BACK DURING PARALLEL INTAKE OF BISOPROLOL, AMLODIPINE AND VALSARTAN/ HCT: NITROSAMINE POLYCONTAMINATION IN THE MULTIMEDICATION AS THE MOST POWERFUL SKIN CANCER TRIGGER.
Tchernev G
Georgian Med News; 2023 Jun; (339):83-88. PubMed ID: 37522780
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of the "Scholastic" Recommendations of the AJCC From 2011 for the Surgical Treatment of Cutaneous Melanoma with the Newly Suggested Guidelines for OSMS From the Bulgarian Society For Dermatologic Surgery!
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2018 Dec; 6(12):2369-2372. PubMed ID: 30607193
[TBL] [Abstract][Full Text] [Related]
7. One Step Melanoma Surgery (OSMS) Without Using Ultrasonography for Preoperative Tumour Thickness Measurement? - "A Question that Sometimes Drives Me Hazy: Am I or Are the Others Crazy!".
Tchernev G; Temelkova I; Stavrov K
Open Access Maced J Med Sci; 2018 Jun; 6(6):1085-1090. PubMed ID: 29983807
[TBL] [Abstract][Full Text] [Related]
8. Multiple Primary Cutaneous Melanomas in a Bulgarian Patient: The Possible Role of One Step Melanoma Surgery (OSMS) As the Most Adequate Treatment Approach!
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2018 Nov; 6(11):2155-2160. PubMed ID: 30559881
[TBL] [Abstract][Full Text] [Related]
9. Innovative One Step Melanoma Surgical Approach (OSMS): Not a Myth-It's a Reality! Case Related Analysis of a Patient with a Perfect Clinical Outcome Reported from the Bulgarian Society for Dermatologic Surgery (BULSDS)!
Tchernev G; Chernin S; Lozev I; Lotti T; Stavrov K; Temelkova I; Pidakev I
Open Access Maced J Med Sci; 2018 Apr; 6(4):673-674. PubMed ID: 29731939
[TBL] [Abstract][Full Text] [Related]
10. The Novel Surgical Margin for One Step Melanoma Surgery (OSMS) (Without Using Ultrasonography Preoperatively): The End of Conformity! "Vivere militare est!".
Tchernev G; Temelkova I
Open Access Maced J Med Sci; 2018 Jul; 6(7):1263-1266. PubMed ID: 30087733
[TBL] [Abstract][Full Text] [Related]
11. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
12. One Step Melanoma Surgery for Patient with Thick Primary Melanomas: "To Break the Rules, You Must First Master Them!".
Tchernev G
Open Access Maced J Med Sci; 2018 Feb; 6(2):367-371. PubMed ID: 29531606
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension.
Israili ZH
J Hum Hypertens; 2000 Apr; 14 Suppl 1():S73-86. PubMed ID: 10854085
[TBL] [Abstract][Full Text] [Related]
14. Meyerson Phenomenon as a Component of Melanoma in situ.
Sezer E; Özturk Durmaz E; Çetin E; Şahin S
Acta Dermatovenerol Croat; 2016 Apr; 24(1):81-2. PubMed ID: 27149137
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
Malacco E; Varì N; Capuano V; Spagnuolo V; Borgnino C; Palatini P;
Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
[TBL] [Abstract][Full Text] [Related]
16. Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.
Ray A; Atal S; Sadasivam B
Glob Cardiol Sci Pract; 2020 Nov; 2020(2):e202025. PubMed ID: 33426042
[TBL] [Abstract][Full Text] [Related]
17. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
18. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
Mann J; Julius S
Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
[TBL] [Abstract][Full Text] [Related]
19. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
Ferri C; Croce G; Desideri G
Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
[TBL] [Abstract][Full Text] [Related]
20. One Step Surgery for Cutaneous Melanoma: "We Cannot Solve Our Problems with the Same Thinking We Used When We Created Them?".
Tchernev G
Open Access Maced J Med Sci; 2017 Oct; 5(6):774-776. PubMed ID: 29104688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
